Current Oncology Reports

Papers
(The median citation count of Current Oncology Reports is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer165
Surgical Management of Melanoma: Advances and Updates107
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review92
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review78
New Developments in VHL-Associated Neuroendocrine Neoplasms59
NRG1 Fusions: The New Kid on the Block49
Immunotherapy in Biliary Tract Cancers: Where Are We?48
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas48
Brain Prehabilitation for Oncologic Surgery44
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting42
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan40
Surgical Stress and Cancer Progression: New Findings and Future Perspectives39
Current Trends and Challenges of Microbiome Research in Prostate Cancer38
Cellular Therapy in NSCLC: Between Myth and Reality38
AXL Inhibitors: Status of Clinical Development38
The Difficult Airway in Patients with Cancer37
Head and Neck Mucosal Melanoma: Where Are We Now?36
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites36
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients35
The Microbiome in Advanced Melanoma: Where Are We Now?34
Targeting the PI3K Pathway in Gynecologic Malignancies31
An Overview of Angiogenesis in Bladder Cancer31
Appendiceal Neuroendocrine Neoplasms: an Update for 202331
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review30
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours28
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations28
Proton Therapy in The Treatment of Head And Neck Cancers- Review28
CAR-T Therapies in Solid Tumors: Opportunities and Challenges26
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?26
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations25
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question25
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer25
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews24
Geographical Disparities in Colorectal Cancer in Canada: A Review24
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma23
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)23
Development of Effective Siglec-9 Antibodies Against Cancer23
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing22
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review22
Surgery for Recurrent Epithelial Ovarian Cancer22
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions22
Vascular Inflammation, Cancer, and Cardiovascular Diseases22
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials21
Evolving Treatment Approaches to Mucosal Melanoma21
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?21
Current Management of Neuroendocrine Tumour Liver Metastases21
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets21
Small Cell and Other Rare Histologic Types of Cervical Cancer20
Current Diagnostic Tools for Breast Cancer-Related Lymphedema20
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging20
Management of Peripheral T-cell Lymphomas and the Role of Transplant20
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer19
Current Status on Management of Primary Plasma Cell Leukemia19
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review19
History of Leukemia, Revisited19
Elderly Rectal Cancer: An Updated Review19
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review19
Epidemiology of Cancer in Older Adults: A Systematic Review18
Multimodality Therapies for Localized Prostate Cancer18
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy18
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma17
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights17
Intratumoral Immunotherapy: Is It Ready for Prime Time?17
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review17
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers17
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives16
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis16
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions16
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours16
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade16
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy16
Return to Intended Oncological Therapy: State of the Art and Perspectives16
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development16
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment15
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL15
CDK4/6 inhibitors: The Devil is in the Detail15
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway15
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer15
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas15
CAR T-cell Therapy for Central Nervous System Lymphoma15
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?15
Racial Disparities in Breast Cancer: from Detection to Treatment15
Lymphatic Interventions in the Cancer Patient15
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations14
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer14
Advances in Treatment of Waldenström Macroglobulinemia14
Integrative Geriatric Oncology: A Review of Current Practices14
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer14
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine14
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers14
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab14
Cardio-Oncology in Childhood: State of the Art14
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer14
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science14
Surviving Burnout as an Oncologist13
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism13
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes13
Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy12
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?12
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review12
Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview12
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis12
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors12
Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors12
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management12
Fertility-Sparing and Less Radical Surgery for Cervical Cancer12
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment12
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner12
Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies12
An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism12
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan12
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies11
Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy11
Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle11
The Microbiome’s Influence on Head and Neck Cancers11
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science11
Germline Mutations and Ancestry in Prostate Cancer11
Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry11
Correction to: Postmastectomy Functional Impairments11
Clinical Applications and Advancements of Positron Emission Tomography/Computed Tomography in Cardio-Oncology: A Comprehensive Literature Review and Emerging Perspectives11
Post-acute Care Needs and Benefits of Inpatient Rehabilitation Care for the Oncology Patient11
Hairy Cell Leukemia: Where Are We in 2023?11
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges11
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm11
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?11
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions11
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach11
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success11
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?11
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths10
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors10
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma10
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors10
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma10
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy10
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer10
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis10
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology10
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)10
Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients10
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival10
Asparaginase: How to Better Manage Toxicities in Adults10
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?10
Melanoma in Pediatric and Young Adult Patients10
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients10
Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors10
Recent Progress in Mind–Body Therapies in Cancer Care10
Radiation and Melanoma: Where Are We Now?10
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder10
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review10
Liver Cancer Etiology: Old Issues and New Perspectives9
Targeted Therapy for Melanomas Without BRAF V600 Mutation9
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review9
Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments9
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned9
Existing Health Inequities in the Treatment of Advanced and Metastatic Cancers9
Update on Percutaneous Ablation for Sarcoma9
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer9
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment9
Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care9
Current Trends and Challenges of Microbiome Research in Bladder Cancer9
Immune-Related Adverse Events in Patients with Lung Cancer9
Ablation of Kidney Tumors in Patients with Substantial Kidney Impairment: Current Status9
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges9
Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines9
De-escalation for Human Papillomavirus-Positive Oropharyngeal Cancer: A Look at the Prospective Evidence9
Translocations and Gene Fusions in Sinonasal Malignancies9
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape9
Advances in Radiation Oncology in Soft Tissue Sarcoma9
Metronomic Chemotherapy in Elderly Patients8
Aromatase Inhibitor Musculoskeletal Syndrome and Bone Loss: a Review of the Current Literature8
Immune Checkpoint Inhibitors in Geriatric Oncology8
The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma8
Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship8
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer8
Percutaneous Management of Breast Cancer: a Systematic Review8
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances8
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis8
Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?8
Non-squamous Cancers of the Larynx8
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment8
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?8
Diagnostic and Therapeutic Updates in Leptomeningeal Disease8
Surgery in the Era of Immunotherapy for Advanced Head and Neck Non-melanoma Skin Cancer8
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer8
Novel Clinical PET Tracers in the Pipeline for Melanoma8
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments8
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?8
Approach to the Older Patient with Acute Myeloid Leukemia8
0.036803960800171